The impact of age on risk assessment, therapeutic practice and outcome in candidemia. [electronic resource]
- Infectious diseases (London, England) 06 2019
- 425-434 p. digital
Publication Type: Journal Article; Observational Study
2374-4243
10.1080/23744235.2019.1595709 doi
Adult Age Factors Aged Aged, 80 and over Antifungal Agents--therapeutic use Candidemia--drug therapy Female Humans Incidence Male Middle Aged Neutropenia--complications Norway--epidemiology Retrospective Studies Risk Assessment Risk Factors Treatment Outcome Young Adult